The Opportunity
The heart of insitro’s strategy is the combination of novel, cutting edge methods in machine learning, biology at scale and drug discovery that address key bottlenecks in the drug development pipeline. To accomplish that, we are putting together an incredible team of highly talented drug discovery scientists who want to make a difference to these significant problems. In this key role, you will help build the Oligonucleotide Therapeutics capabilities at insitro and Drug Discovery department. Your primary duties will include (i) guide oligonucleotide efforts in projects as project team leader (ii) build insitro’s oligonucleotide therapeutic capabilities through extensive CRO or industry collaborations (iii) work cross-functionally to drive oligonucleotide projects through different stage gates towards clinical development candidates (iv) deeply engage cross-functionally to evaluate new targets towards drug discovery efforts.
You will be joining a growing biotech startup that has long-term stability due to significant funding, but yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us, and help make a difference to patients!
About You
- PhD in chemistry with 8+ years of industry experience in drug discovery, with 5+ years of direct experience in oligonucleotide drug design
- Deep understanding of the oligonucleotide drug discovery process
- Demonstrated track record of leadership advancing oligonucleotide projects through different stages of drug discovery and early-stage development
- Proven leadership capabilities in cross-functional teams as project team leader
- First hand experience in setting up and using CROs for oligonucleotide drug discovery
- Track record of innovation and impact on projects through peer-reviewed publication and/or patent applications
- Excellent written and verbal communication skills across multi-functional teams
- Intellectual curiosity to push the boundaries of drug discovery
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $215,000 - $235,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, the level at which they are actually hired, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
- 401(k) plan with employer matching for contributions
- Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees), as well as mental health and well-being support
- Open, flexible vacation policy
- Paid parental leave
- Quarterly budget for books and online courses for self-development
- Support to occasionally attend professional conferences that are meaningful to your career growth and development
- New hire stipend for home office setup
- Monthly cell phone & internet stipend
- Access to free onsite baristas and cafe with daily lunch and breakfast
- Access to free onsite fitness center
- Commuter benefits
#LI-DH1 #LI-Hybrid
About insitro
insitro is a data-driven drug discovery and development company using machine learning and data at scale to transform the way that drugs are discovered and developed for patients. insitro is developing predictive machine learning models to discover underlying biologic state based on human cohort data and in-house generated cellular data at scale. These predictive models can be brought to bear on key bottlenecks in pharmaceutical R&D to advance novel targets and patient biomarkers, design therapeutics, and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of biologic insights and molecules in neuroscience and metabolic diseases. Since formation in mid 2018, insitro has raised over $700 million from top tech, biotech, and crossover investors and from collaborations with pharmaceutical partners. For more information on insitro, please visit the company’s website at www.insitro.com .